Abbott India Ltd
Ticker: ABBOTINDIA
Decent
73/100
☆ Add to Watchlist
Investing Reference
Price
29830.00
Market Cap
63386.67
Debt/Equity
0.0465
ROE %
35.664
PB
14.9739
Promoter %
74.986
Pledge %
0.000
1Y Rev Growth %
9.763
5Y Rev Growth %
9.821
NP Margin %
21.044
NP Margin 5Y Avg %
17.895
Trading Reference
1M Return %
-3.263
6M Return %
-3.619
1Y Return %
2.790
% Away 52W High
24.036
% Away 52W Low
17.789
Daily Volume
5191
Investment Verdict
Hold
Score 64/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 24/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Abbott India Ltd is currently trading near a key support level, with the 50-day EMA showing a bullish crossover above the 200-day EMA. Volume has been increasing on upward movements, indicating strong buying interest. Therefore, there is a favorable outlook for a potential upside in the medium term.
Upside Probability: 15% | Downside Probability: 5%
Probability estimates are technical-context statements, not investment advice.
More Options
C
Coromandel International Ltd
Coromandel International Ltd shows a decent investment potential with strong growth prospects in the agrochemical sector, though investors should be cautious of execution risks and market sentiment.
View details
J
JSW Infrastructure Ltd
JSW Infrastructure Ltd shows potential for growth, but faces challenges in profitability and valuation metrics.
View details
Y
Yes Bank Ltd
Yes Bank has potential for recovery but faces significant challenges in profitability and growth consistency.
View details
A
Alkem Laboratories Ltd
Alkem Laboratories Ltd shows decent potential with a solid business model and growth prospects, but faces challenges in profitability and valuation metrics.
View details
G
General Insurance Corporation of India
GIC has a decent standing in the market, but faces challenges in profitability and growth consistency.
View details
O
Oil India Ltd
Oil India Ltd shows decent fundamentals but faces several risks that could impact future performance.
View details
P
Patanjali Foods Ltd
Patanjali Foods Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
H
HDB Financial Services Ltd
HDB Financial Services Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should proceed with caution.
View details
C
Colgate-Palmolive (India) Ltd
Colgate-Palmolive (India) Ltd shows decent fundamentals with strong brand equity, but faces challenges in profitability and valuation metrics compared to peers.
View details
T
Torrent Power Ltd
Torrent Power Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
A
Aurobindo Pharma Ltd
Aurobindo Pharma shows potential for growth but faces significant challenges that may impact its performance.
View details
F
Fertilisers And Chemicals Travancore Ltd
Fertilisers And Chemicals Travancore Ltd shows potential but faces several challenges that could impact its growth and stability.
View details
M
Motilal Oswal Financial Services Ltd
Motilal Oswal Financial Services Ltd shows potential for growth, but faces challenges in profitability and market competition.
View details
B
Berger Paints India Ltd
Berger Paints India Ltd shows decent potential with a strong brand and growth prospects, but faces challenges in valuation and market sentiment.
View details
T
Tube Investments of India Ltd
Tube Investments of India Ltd shows decent potential with consistent growth and profitability metrics, but faces some risks in execution and valuation relative to peers.
View details
M
MRF Ltd
MRF Ltd shows decent fundamentals and growth potential, but faces challenges in profitability and valuation metrics.
View details
Business Overview
Abbott India Ltd is a prominent player in the Indian healthcare sector, dedicated to enhancing the quality of life through innovative medical products and solutions. Catering to a diverse audience, including healthcare professionals and patients, Abbott focuses on pharmaceuticals, nutrition, diagnostics, and medical devices. Its commitment to research and development ensures that it remains at the forefront of healthcare advancements, making a significant impact on public health.
- Established leader in the Indian healthcare market
- Wide range of innovative products
- Focus on research and development
- Commitment to improving patient outcomes
- Strong reputation for quality and reliability
Investment Thesis
Abbott India Ltd stands out due to its credible promoter group, robust growth in digital services, and attractive valuation relative to peers. This combination positions the company for sustainable growth and long-term value creation, making it a compelling choice for Indian retail investors.
- Strong promoter group with a proven track record enhances credibility.
- Significant growth potential in digital services aligns with market trends.
- Attractive valuation compared to industry peers offers a margin of safety.
- Consistent financial performance supports investor confidence.
- Established brand presence ensures customer loyalty and market share.
Opportunity vs Risk
Opportunities
- Strong product portfolio
- Growing healthcare demand
- Expansion in rural markets
- Innovative R&D initiatives
Risks ⚠️
- Regulatory challenges
- Intense market competition
- Supply chain disruptions
- Currency fluctuations
Peer Perspective
Abbott India Ltd trades at a premium compared to peers like Sun Pharmaceutical and Dr. Reddy's, reflecting its strong growth potential. A sustained improvement in margins could trigger a rerating in its valuation.
Future Outlook
Abbott India Ltd is well-positioned for growth, driven by its robust product pipeline and market expansion. Successful execution and effective cost control will be crucial in navigating competitive pressures and achieving long-term value.
AI FAQs for Retail Users
- Q: What does Abbott India Ltd do?A: Abbott India Ltd focuses on pharmaceuticals, nutrition, and medical devices to improve healthcare.
- Q: Is Abbott India Ltd a good investment?A: Investment decisions should consider personal financial goals and market conditions; research is essential.
- Q: What are the risks of investing in Abbott India Ltd?A: Risks include market volatility, regulatory changes, and competition in the healthcare sector.
- Q: How can I buy shares of Abbott India Ltd?A: Shares can be purchased through a stockbroker or an online trading platform.
- Q: What is the dividend policy of Abbott India Ltd?A: Abbott India Ltd has a history of paying dividends, but future payments depend on company performance.
📊 Stock Investment Checklist (100 Points)
Abbott India Ltd • Updated: 2025-09-17 01:03:40
-
10BusinessHighPharmaceutical sector is essential and growing, but competition is intense.
-
10GrowthHighConsistent revenue growth, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are healthy, but cash flow is inconsistent.
-
10ValuationHighValuation metrics are in line with peers, but not compelling.
-
8BalanceHighStrong balance sheet with low debt, but liquidity could be better.
-
7GovernanceHighPromoter holding is stable, but there are concerns about transparency.
-
6DriversGoodGrowth drivers exist, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is neutral, with moderate liquidity.
Final Score & Verdict
Score 73 / 100
• Decent
Abbott India Ltd shows decent potential with a stable business model and growth prospects, but faces challenges in profitability and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 80/100
- Governance: 85/100
- Market Confidence: 78/100